Leukotrienes during rejection after canine pancreatic allotransplantation.
Shimizu
K
K
Second Department of Surgery, School of Medicine, Kanazawa University, Ishikawa, Japan.
Izumi
R
R
Horichi
H
H
Yagi
M
M
Hashimoto
T
T
Watanabe
T
T
Iyobe
T
T
Iwasa
K
K
Ii
T
T
Fukushima
W
W
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D016227:Benzoquinones / Q000494:pharmacology; D004285:Dogs; D006084:Graft Rejection / Q000097:blood*; D007975:Leukotriene B4 / Q000097:blood* / Q000378:metabolism; D016859:Lipoxygenase Inhibitors; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology*; D013929:Thromboxane B2 / Q000097:blood; D013997:Time Factors; D014184:Transplantation, Homologous
D016227:Benzoquinones; D016859:Lipoxygenase Inhibitors; D007975:Leukotriene B4; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C036837:2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone